A Study of MD-7246 to Treat Abdominal Pain in Patients With Diarrhea-predominant Irritable Bowel Syndrome

Clinical trial NCT03931785 · COMPLETED

Trial details

NCT number: NCT03931785
Sponsor: Ironwood Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Irritable Bowel Syndrome With Diarrhea (IBS-D)

Start date: 2019-05-01
Primary completion: 2020-02-26
Enrollment: 515

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.